EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic overlap between treatment-resistant schizophrenia and smoking initiation

Elise Koch iD, Nadine Parker, Helin H Mohammad, Hasan Ç Lenk, Lars A R Ystaas, Piotr Jaholkowski iD, Alexey A Shadrin, Oleksandr Frei, Anders M Dale, Srdjan Djurovic, Espen Molden iD, Kevin S O'Connell und 1 weitere

International Journal of Neuropsychopharmacology · 01.07.2026 · 29 (7)

DOI: 10.1093/ijnp/pyag035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 28.06.2026. Verfasst von Elise Koch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of…. Hauptthemen laut MEDLINE: Schizophrenia, Treatment-Resistant, Smoking, Cigarette Smoking, Schizophrenia. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU HORIZON-HLTH-2021, European Union's Horizon 2020 research and innovation programme, South-East Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early detection of treatment-resistant schizophrenia (TRS) is of substantial clinical importance. While TRS is heritable, the associated genetic variants have been difficult to identify. Cigarette smoking is associated with non-response to antipsychotics, and smoking behavior and schizophrenia have a shared genetic basis. Thus, TRS may also have a shared genetic basis with smoking behavior.

Objective

Here, we aim to identify genetic variants associated with TRS by leveraging overlapping genetic variants with smoking initiation to increase statistical power.

Methods

We analyzed genome-wide data for TRS and smoking initiation with the conditional/conjunctional false discovery rate (cond/conjFDR) to identify shared loci, and LD score regression to determine genetic correlations. To investigate potential causal effects of shared loci, we performed Mendelian randomization analyses. Shared loci were mapped to genes, which were further investigated for enrichment of drug target genes.

Results

We observed a significant positive genetic correlation between TRS and smoking initiation (rg = 0.47 P = .0002). Leveraging the genetic overlap between TRS and smoking initiation, we identified four novel loci jointly associated with TRS and smoking initiation. The condFDR results improved polygenic prediction of TRS. Mendelian randomization indicates putative evidence for a causal effect of genetic liability to TRS on smoking initiation. The functional genetic analyses suggest that alpha-1-adrenergic receptors may be involved in the pathophysiology of TRS and possibly related to the efficacy of clozapine versus other antipsychotic drugs.

Conclusion

In conclusion, our results show that shared genetic mechanisms influence both TRS and smoking behavior, which provide new insights into the biological underpinnings of TRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schizophrenia, Treatment-ResistantSmokingCigarette SmokingSchizophreniaHumansGenome-Wide Association StudyGenetic Predisposition to DiseaseMendelian Randomization AnalysisAntipsychotic Agents

Stichwörter der Autor:innen

GWASclozapinegeneticssmokingtreatment-resistant schizophrenia

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Center for Bioinformatics, Department of Informatics, University of Oslo, 0316, Oslo, Norway.
  • Center for Multimodal Imaging and Genetics, J. Craig Venter Institute, La Jolla, CA, United States.

ORCID-Profile: Elise Koch, Piotr Jaholkowski, Espen Molden

Förderung

  • EU HORIZON-HLTH-2021
  • European Union's Horizon 2020 research and innovation programme
  • South-East Norway Regional Health Authority
  • Research Council of Norway
  • UNINETT Sigma2-the National Infrastructure for High Performance Computing and Data Storage in Norway
  • European Union’s Horizon 2020 research and innovation programme
  • UNINETT Sigma2—the National Infrastructure for High Performance Computing and Data Storage in Norway

Zitieren

APA

Koch, E., Parker, N., Mohammad, H. H., Lenk, H. Ç., Ystaas, L. A. R., Jaholkowski, P., Shadrin, A. A., Frei, O., Dale, A. M., Djurovic, S., Molden, E., O'Connell, K. S., & Andreassen, O. A. (2026). Genetic overlap between treatment-resistant schizophrenia and smoking initiation. International Journal of Neuropsychopharmacology, 29(7). https://doi.org/10.1093/ijnp/pyag035

Vancouver

Koch E, Parker N, Mohammad HH, Lenk HÇ, Ystaas LAR, Jaholkowski P, et al. Genetic overlap between treatment-resistant schizophrenia and smoking initiation. International Journal of Neuropsychopharmacology. 2026;29(7). doi:10.1093/ijnp/pyag035

BibTeX
@article{Koch2026,
  author = {Koch, Elise and Parker, Nadine and Mohammad, Helin H and Lenk, Hasan Ç and Ystaas, Lars A R and Jaholkowski, Piotr and Shadrin, Alexey A and Frei, Oleksandr and Dale, Anders M and Djurovic, Srdjan and Molden, Espen and O'Connell, Kevin S and Andreassen, Ole A},
  title = {Genetic overlap between treatment-resistant schizophrenia and smoking initiation},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2026},
  volume = {29},
  number = {7},
  doi = {10.1093/ijnp/pyag035}
}
Kostenlos starten →